The patient initially came to see Mark Supiano in 2017 because her family was concerned about her short-term memory loss. While taking her history and vital signs, Supiano, a geriatrician at the University of Utah, saw one disturbing signal: Her blood pressure was 148/86, above normal despite her taking two medications intended to lower it….
EHIgnite Challenge’s goal is to solve the problem of hard-to-integrate raw data and better support clinical care and patient engagement
[Sponsored] A new eBook published by MedCity News for PurpleLab highlights how RWD and SDOH can lead to more inclusive clinical trials and drugs that improve the quality of life for larger, diverse patient populations not only for NSCLC, but other conditions as well. The post Using Real World Data from the Patient Experience to…
Novo Nordisk is acquiring Akero Therapeutics for drug candidate efruxifermin, which executive say could be first and best in the emerging class of FGF21 analogs for the fatty liver disease MASH. The deal comes months after Novo’s internal FGF21 drug candidate failed a Phase 2 trial. The post With $4.7B Akero Acquisition, Novo Nordisk Maps…
If the One Big Beautiful Bill Act is signed into law, it would result in a $50.4 billion reduction in federal Medicaid spending on rural hospitals over the next decade, which could put 338 rural hospitals at risk of closure, according to new analyses. The post How Badly Would Medicaid Cuts Hurt Healthcare Access in…
There is no excerpt because this is a protected post.
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health News’ “What the Health?” She previously spent more than a decade reporting on the federal government, most recently covering surprise medical bills, drug pricing reform, and other health policy debates…
Quibim’s technology applies artificial intelligence analysis to medical images to detect biomarkers. Hospitals and biopharma companies are among the startup’s customers, using its technology to analyze images to detect disease and guide clinical trial enrollment. The post Medtech Startup Quibim Corrals $50M to Advance AI Analysis in Medical Imaging appeared first on MedCity News.
Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguci said. The post Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More…
On What the Health? From KFF Health News, distributed by WAMU, chief Washington correspondent and host Julie Rovner sat down with Drew Altman, president and CEO of KFF, to talk about the likelihood of a national health care debate to rein in costs. As the midterm elections approach, the cost of health care is the…